Thalix 50mg Capsule
Prescription Required
Marketed By
fresenius kabi india
Pack of
3x10 capsule
Salt Composition
Thalidomide
Storage
Keep in cold place
₹256.67₹332.78
22.87% Off
Inclusive of all taxes
1
Thalix 50mg Capsule
Delivering To: —
All Substitutes
Overview
Thalix 50mg Capsule is an immunomodulatory agent. It is used in the treatment of multiple myeloma and lepra reactions. This medicine kills the cancer cells and helps to prevent their growth in the body. It is important to take this medicine as prescribed by your doctor. After the oral administration, the effect of this medicine can be observed in 2-5 hours.
Indication
Blood Cancer
Side Effects
Thalix 50mg Capsule shows some side effects. Some of the mild ones do not need any medical attention, and they go away as the body adapts to the medicine. It is important to consult your doctor if they persist for a longer time and are deteriorating your health:
Common side effects include:
Dizziness
Chest pain
Headache
Muscle weakness
Anxiety
Blood clots
Fever
Weight gain
Fatigue
Constipation
Decreased white blood cell count
Swelling
Loss of appetite
Irregular heartbeat
Nausea
Inform your doctor immediately if you experience any persistent or unusual side effects.
How To Use
The doctor determines the dosage and duration of treatment with Thalix 50mg Capsule as per the patient's health condition. This medicine should be taken orally at the same time every day. Take it as a whole and don't crush or chew the medicine. This tablet can be taken with or without food. It is advised to take this medicine after consulting your healthcare expert.
How It Works
Thalix 50mg Capsule is an immunomodulatory agent that works by modulating the activity of the body's immune system and helps in indirectly attacking the cancer cells. This medicine stops the growth of blood vessels in cancer, inhibits the multiplication of cancer cells, and stimulates the immune system to attack cancer cells. This is how it treats and manages Multiple Myeloma and Lepra reactions.
Safety Advice
Alcohol
unsafe
Avoid the consumption of alcohol while taking Thalix 50mg Capsule, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Do not take Thalix 50mg Capsule without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
consult your doctor
Thalix 50mg Capsule is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Thalix 50mg Capsule may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
caution
Thalix 50mg Capsule is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Liver
caution
Thalix 50mg Capsule is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Missed Doses
It is advisable not to miss a dose of Thalidomide 50mg Capsule. If you miss a scheduled dose of these capsules, contact your doctor immediately.
FAQs
It is used in the treatment of multiple myeloma and lepra reactions. This medicine kills the cancer cells and helps to prevent their growth in the body.
This capsule modulates the activity of the body’s immune system and helps in attacking the cancer cells.
Some common side effects are dizziness, chest pain, anxiety, headache, muscle weakness, sore throat, bleeding, pale skin, vomiting, etc.
It is important to take this medicine as prescribed by your doctor.
Follow your doctor’s advice about any restrictions on food and other activities.
Reference
1. Iyer, C. G. S., Languillon, J., Ramanujam, K., Tarabini-Castellani, G., De Las Aguas, J. T., Bechelli, L. M., ... & Sundaresan, T. (1971). WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bulletin of the World Health Organization, 45(6), 719.
2. Padhi, T., & Sethy, M. (2019). Lepra reactions. In Dermatological Emergencies (pp. 535-543). CRC Press.
3. Thompson, J. L., & Hansen, L. A. (2003). Thalidomide dosing in patients with relapsed or refractory multiple myeloma. Annals of Pharmacotherapy, 37(4), 571-576.
4. Mateos, M. V. (2010). Management of treatment-related adverse events in patients with multiple myeloma. Cancer treatment reviews, 36, S24-S32.
5. Hattori, Y., & Iguchi, T. (2004). Thalidomide for the treatment of multiple myeloma. Congenital anomalies, 44(3), 125-136.
Related Products
MARKETER DETAILS
fresenius kabi india
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.